Cancer discovery news
Our researchers are making the discoveries that defeat cancer. Read the latest findings from our world-leading research.
Visit our main news hub to read about news on new funding, our fundraising activities and much more. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
ASCO 2021: Trial shows benefits of targeted drug against early-stage breast cancer with inherited BRCA mutation
Women with high-risk, early-stage breast cancer who also have inherited faults in their BRCA1 or BRCA2 genes have shown a remarkable response to the targeted drug olaparib in a major clinical trial.
ASCO 2021: New ‘search and destroy’ treatment extends life in advanced prostate cancer
A new high-tech drug treatment for prostate cancer, which delivers a precisely targeted dose of radiation to cancer cells, can keep patients alive and healthy for longer, a new phase III trial reports.
ICR announces new Chair of Board of Trustees
Professor Julia Buckingham CBE, an acclaimed medical researcher with exceptional leadership experience in academic institutions and across the sector, will become Chair of The Institute of Cancer Research, London, in August.
.jpg?sfvrsn=c0e17b74_2 "Pills (4.3)")
Study polypharmacology earlier in drug discovery, say researchers
Polypharmacology – the ability of a drug to affect more than one protein – should be studied early in the drug discovery pathway, and constantly monitored as the chemical structure is optimised in the design of the clinical candidate, leading researchers believe.
Scientists make ‘long-range weather forecasts’ of bowel cancer’s drug resistance
Scientists can use genetic ‘weather forecasting’ to predict how long it will take for bowel cancer to evolve resistance to a drug before a patient has even started treatment, a new study has shown.
-content.tmb-hbmobile.jpg?Culture=en&sfvrsn=fec93f9d_2 "Dispensing medicines for a clinical trial (Jan Chlebik for the ICR, 2014) content")
From breakthroughs to patient benefits: inside the ICR’s Clinical Trials and Statistics Unit
In this feature, Molly Andrews takes a close look at how the ICR’s Clinical Trials and Statistics Unit is turning scientific advances into benefits for patients, through cutting-edge clinical trials.
ICR among country’s top universities in first Knowledge Exchange Framework
The Institute of Cancer Research, London, has ranked highly in the UK’s first Knowledge Exchange Framework (KEF), a new Government assessment of universities’ partnerships and their influence on wider society.
Prince of Wales visits the Breast Cancer Now Toby Robins Research Centre at ICR
Today, His Royal Highness The Prince of Wales visited the Breast Cancer Now Toby Robins Research Centre, at The Institute of Cancer Research, London, 21 years after he officially opened it as the UK’s first dedicated breast cancer research centre in 1999.
Leading breast cancer researcher elected as Fellow of the Academy of Medical Sciences
Professor Nicholas Turner has been recognised with a prestigious Fellowship of the Academy of Medical Sciences for his excellence in breast cancer research and outstanding contribution to the field.
New type of treatment could reawaken immune response against prostate cancer
Targeting a molecule on the surface of immune cells could offer an exciting new way to treat prostate cancer by reawakening the immune response against it.
ICR announces appointment of new Chief Executive
Professor Kristian Helin, a world-leading cancer researcher with exceptional leadership experience in three different countries, will become Chief Executive of The Institute of Cancer Research, London, in September.
Ovarian cancer drug offers new genetically targeted approach against range of cancers
A type of drug used against ovarian and breast cancers could offer a brand new targeted approach for treating a range of cancers with particular genetic defects, including a common form of kidney cancer.